Understanding the molecular characteristics of cancer that impact patient outcomes is essential to identifying novel treatment strategies for the most intractable pediatric malignancies. Many of these diseases are difficult to study, however, due to the small number of patients diagnosed each year. Investigators from St. Jude Children’s Research Hospital and an international collaborative group of more than 50 researchers joined forces to understand better a type of rare childhood leukemia—gamma delta T-cell acute lymphoblastic leukemia (?? T-ALL). The findings revealed a high-risk subtype of the disease and a genomic vulnerability Read More